THERAVANCE BIOPHARMA INC shareholders Q3 2023

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

THERAVANCE BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
DIMENSIONAL FUND ADVISORS LP 71,620$617,4250.00%
US BANCORP \DE\ 1,000$8,6300.00%
Parallel Advisors, LLC 239$2,0630.00%
PNC FINANCIAL SERVICES GROUP, INC. 144$1,2420.00%
FIRST MANHATTAN CO. LLC. 0$00.00%
WELLS FARGO & COMPANY/MN 14,942$128,9510.00%
AMERICAN CENTURY COMPANIES INC 36,123$311,7410.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 23,798$205,3770.00%
Legal & General Group Plc 55,381$477,9390.00%
BALYASNY ASSET MANAGEMENT L.P. 13,699$118,2220.00%
JANUS HENDERSON GROUP PLC 24,937$214,9600.00%
NATIXIS 2,000$17,2600.00%
PRICE T ROWE ASSOCIATES INC /MD/ 48,023$4150.00%
NEW YORK STATE COMMON RETIREMENT FUND 18,994$1640.00%
NISA INVESTMENT ADVISORS, LLC 40$3450.00%
MARSHALL WACE, LLP 20,400$176,0520.00%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 17,681$152,5870.00%
TORONTO DOMINION BANK 43$3710.00%
DEUTSCHE BANK AG\ 28,135$242,8050.00%
External links

This page lists THERAVANCE BIOPHARMA INC's shareholders in Q3 2023. To view THERAVANCE BIOPHARMA INC's shareholder history, click here.